Greenlight Capital added a stake in Centene Corporation (CNC) on a recent market dip, while Crossmark Global Holdings reduced its position. CNC has appointed a first president overseeing Individual Coverage Health Reimbursement Arrangements (ICHRA). Despite experiencing some recent market performance volatility, Centene’s financials remain strong, encouraging investors’ confidence for long-term value. Even as the stock has seen movement, outlets suggest that this healthcare stock are presently undervalued.
CFO, Asher Andrew Lynn, recently purchased $1 million of the company’s stock. Further, Centene’s Q3 2024 earnings surpassed estimates, reporting an
EPS of $1.36 and $42.0 billion in revenue. Despite this,
Jefferies downgraded Centene shares to underperform based on concerns. Large institutional investors' positions including Nisa Investment Advisors and Diversified Trust have been reduced. On a positive note, Centene reaffirmed its 2024 earnings guidance. Despite some market shifts, stock analysis points towards a promising future for Centene.
Centene Corporation CNC News Analytics from Sun, 26 May 2024 07:00:00 GMT to Sat, 25 Jan 2025 12:35:24 GMT -
Rating -1
- Innovation 4
- Information 7
- Rumor 0
